We are live on ! Find out more
FA

Forefront Analytics Portfolio holdings

AUM $110M
1-Year Est. Return 18.54%
This Fund
S&P 500
This Quarter Est. Return
+4.59%
1 Year Est. Return
+18.54%
3 Year Est. Return
+33.55%
5 Year Est. Return
+24.76%
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$3.68M
Cap. Flow
-$4.19M
Cap. Flow %
-2.03%
Top 10 Hldgs %
53.21%
Holding
70
New
3
Increased
29
Reduced
34
Closed
3

Top Buys

1
NULV icon
Nuveen ESG Large-Cap Value ETF
NULV
+$14.7M
2
FLRN icon
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
+$209K
3
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$206K
4
UNH icon
UnitedHealth
UNH
+$145K
5
ALXO icon
ALX Oncology
ALXO
+$144K

Top Sells

1
ESGD icon
iShares ESG Aware MSCI EAFE ETF
ESGD
+$12.2M
2
ESG icon
FlexShares STOXX US ESG Select Index Fund
ESG
+$4.64M
3
ESGG icon
FlexShares STOXX Global ESG Select Index Fund
ESGG
+$648K
4
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$434K
5
MTUM icon
iShares MSCI USA Momentum Factor ETF
MTUM
+$335K

Sector Composition

1 Healthcare 1.51%
2 Technology 0.76%
3 Financials 0.32%
4 Industrials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
51
Pfizer
PFE
$143B
$357K 0.17%
12,860
+2,531
+25% +$70.2K
REGN icon
52
Regeneron Pharmaceuticals
REGN
$70.9B
$331K 0.16%
344
+25
+8% +$23.8K
INCY icon
53
Incyte
INCY
$23.4B
$315K 0.15%
5,531
+863
+18% +$51.8K
TMO icon
54
Thermo Fisher Scientific
TMO
$198B
$295K 0.14%
506
+69
+16% +$38.7K
MDT icon
55
Medtronic
MDT
$106B
$257K 0.12%
2,952
+516
+21% +$44K
MREO
56
Mereo BioPharma
MREO
$49.5M
$145K 0.07%
43,817
+7,693
+21% +$26K
COGT icon
57
Cogent Biosciences
COGT
$6.68B
$130K 0.06%
19,275
-707
-4% -$4.37K
ACHL
58
DELISTED
Achilles Therapeutics
ACHL
$119K 0.06%
95,445
+19,176
+25% +$20.7K
ALXO icon
59
ALX Oncology
ALXO
$283M
$114K 0.06%
+10,261
New +$144K
ANNX icon
60
Annexon
ANNX
$950M
$106K 0.05%
14,818
-16,462
-53% -$85.5K
KRON
61
DELISTED
Kronos Bio
KRON
$100K 0.05%
77,131
+27,963
+57% +$31.9K
TVTX icon
62
Travere Therapeutics
TVTX
$5.27B
$93.1K 0.05%
+12,080
New +$102K
ZURA icon
63
Zura Bio
ZURA
$518M
$87.5K 0.04%
34,038
+12,809
+60% +$45.4K
PSTX
64
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$85.4K 0.04%
26,780
+1,311
+5% +$4.37K
GERN icon
65
Geron
GERN
$924M
$59K 0.03%
17,876
-10,440
-37% -$23.4K
LONA
66
LeonaBio Inc
LONA
$67.8M
$56.5K 0.03%
2,062
-915
-31% -$29K
CTMX icon
67
CytomX Therapeutics
CTMX
$788M
$45.5K 0.02%
20,889
-9,957
-32% -$18.4K
ESG icon
68
FlexShares STOXX US ESG Select Index Fund
ESG
$131M
– –
-39,972
Closed -$4.64M
NKTX icon
69
Nkarta
NKTX
$186M
– –
-20,767
Closed -$137K
FUSN
70
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-16,715
Closed -$161K
1 2
3

Similar funds

NC
nVerses Capital Wellington, Florida $110M AUM
PXPO
Peak XV Partners Operations Trianon, Mauritius $110M AUM 43.09% 1-Year Est. Return
OWA
OakTrust Wealth Advisors Wilton, Connecticut $110M AUM
MCM
Masterton Capital Management New York $110M AUM 3.55% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return
NA
NWM Advisors San Luis Obispo, California $110M AUM
NMC
New Mountain Capital New York $110M AUM 51.63% 1-Year Est. Return
BCM
Bond Capital Management San Francisco, California $110M AUM 16.91% 1-Year Est. Return

Forefront Analytics's Q1 2024 Portfolio in Review

As of Q1 2024, Forefront Analytics held 70 positions worth $206M, up 1.8% from $203M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Forefront Analytics's Q1 2024 filing shows 3 new, 29 increased, 34 reduced and 3 closed positions. Its largest new stake was Nuveen ESG Large-Cap Value ETF: 399,284 shares worth $15.5M. The largest sale was iShares ESG Aware MSCI EAFE ETF, an estimated $12.2M.

By sector, the portfolio is most concentrated in Healthcare at 1.5% of assets, up from 1.3% a quarter earlier, followed by Technology and Financials.

  • Forefront Analytics's largest Q1 2024 buy was Nuveen ESG Large-Cap Value ETF: 399,284 shares worth $15.5M.
  • Forefront Analytics added most to State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q1 2024, an estimated $209K increase.
  • Forefront Analytics's biggest Q1 2024 reduction was iShares ESG Aware MSCI EAFE ETF, cutting an estimated $12.2M.
  • Forefront Analytics fully exited FlexShares STOXX US ESG Select Index Fund in Q1 2024, selling an estimated $4.64M.
  • Forefront Analytics's ten largest holdings make up 53% of its $206M portfolio in Q1 2024.
  • Forefront Analytics opened 3 new positions and closed 3 in Q1 2024.
  • Forefront Analytics's portfolio value rose 1.8% quarter-over-quarter to $206M.

Based on Forefront Analytics's 13F filing for Q1 2024, filed 15 May 2024.